Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population

BACKGROUND: Quantify association between the glucagon-like peptide-1 receptor agonist liraglutide and risk of thyroid cancer (TC) compared to other antidiabetics. PATIENTS AND METHODS: Initiators of liraglutide, exenatide, metformin, pioglitazone or groups of dipeptidyl peptidase-4 inhibitors or sul...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diabetes Metab Syndr Obes
Asıl Yazarlar: Funch, Donnie, Mortimer, Kathleen, Ziyadeh, Najat J, D Seeger, John, Zhou, Li, Ng, Eva, Ross, Douglas, Major-Pedersen, Atheline, Bosch-Traberg, Heidrun, Gydesen, Helge, Dore, David D
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2021
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8203194/
https://ncbi.nlm.nih.gov/pubmed/34140791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S305496
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller